Integrated Biopharma Stock Technical Analysis
| INBP Stock | USD 0.34 0.02 5.56% |
As of the 28th of January, Integrated Biopharma retains the Risk Adjusted Performance of 0.0559, market risk adjusted performance of (1.84), and Downside Deviation of 5.33. Integrated Biopharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed nineteen technical drivers for Integrated Biopharma, which can be compared to its competitors.
Integrated Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Integrated, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IntegratedIntegrated |
Integrated Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Integrated Biopharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Integrated Biopharma.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Integrated Biopharma on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Integrated Biopharma or generate 0.0% return on investment in Integrated Biopharma over 90 days. Integrated Biopharma is related to or competes with Hanover Foods, Indofood Agri, Hi-Great Group, BAB, and Inter-Rock Minerals. Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutr... More
Integrated Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Integrated Biopharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Integrated Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.33 | |||
| Information Ratio | 0.0463 | |||
| Maximum Drawdown | 24.49 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 9.68 |
Integrated Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Integrated Biopharma's standard deviation. In reality, there are many statistical measures that can use Integrated Biopharma historical prices to predict the future Integrated Biopharma's volatility.| Risk Adjusted Performance | 0.0559 | |||
| Jensen Alpha | 0.2801 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0377 | |||
| Treynor Ratio | (1.85) |
Integrated Biopharma January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0559 | |||
| Market Risk Adjusted Performance | (1.84) | |||
| Mean Deviation | 2.74 | |||
| Semi Deviation | 2.9 | |||
| Downside Deviation | 5.33 | |||
| Coefficient Of Variation | 1547.26 | |||
| Standard Deviation | 4.33 | |||
| Variance | 18.76 | |||
| Information Ratio | 0.0463 | |||
| Jensen Alpha | 0.2801 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0377 | |||
| Treynor Ratio | (1.85) | |||
| Maximum Drawdown | 24.49 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 9.68 | |||
| Downside Variance | 28.4 | |||
| Semi Variance | 8.41 | |||
| Expected Short fall | (5.94) | |||
| Skewness | 0.9224 | |||
| Kurtosis | 2.33 |
Integrated Biopharma Backtested Returns
Integrated Biopharma appears to be out of control, given 3 months investment horizon. Integrated Biopharma holds Efficiency (Sharpe) Ratio of 0.068, which attests that the entity had a 0.068 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Integrated Biopharma, which you can use to evaluate the volatility of the firm. Please utilize Integrated Biopharma's Market Risk Adjusted Performance of (1.84), downside deviation of 5.33, and Risk Adjusted Performance of 0.0559 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Integrated Biopharma holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of -0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Integrated Biopharma are expected to decrease at a much lower rate. During the bear market, Integrated Biopharma is likely to outperform the market. Please check Integrated Biopharma's potential upside, as well as the relationship between the kurtosis and period momentum indicator , to make a quick decision on whether Integrated Biopharma's current trending patterns will revert.
Auto-correlation | 0.37 |
Below average predictability
Integrated Biopharma has below average predictability. Overlapping area represents the amount of predictability between Integrated Biopharma time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Integrated Biopharma price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Integrated Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Integrated Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Integrated Biopharma Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Integrated Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Integrated Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Integrated Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Integrated Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Integrated Biopharma price pattern first instead of the macroeconomic environment surrounding Integrated Biopharma. By analyzing Integrated Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Integrated Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Integrated Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Integrated Biopharma January 28, 2026 Technical Indicators
Most technical analysis of Integrated help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Integrated from various momentum indicators to cycle indicators. When you analyze Integrated charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0559 | |||
| Market Risk Adjusted Performance | (1.84) | |||
| Mean Deviation | 2.74 | |||
| Semi Deviation | 2.9 | |||
| Downside Deviation | 5.33 | |||
| Coefficient Of Variation | 1547.26 | |||
| Standard Deviation | 4.33 | |||
| Variance | 18.76 | |||
| Information Ratio | 0.0463 | |||
| Jensen Alpha | 0.2801 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0377 | |||
| Treynor Ratio | (1.85) | |||
| Maximum Drawdown | 24.49 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 9.68 | |||
| Downside Variance | 28.4 | |||
| Semi Variance | 8.41 | |||
| Expected Short fall | (5.94) | |||
| Skewness | 0.9224 | |||
| Kurtosis | 2.33 |
Integrated Biopharma January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Integrated stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 0.34 | ||
| Day Typical Price | 0.34 | ||
| Price Action Indicator | (0.01) |
Additional Tools for Integrated OTC Stock Analysis
When running Integrated Biopharma's price analysis, check to measure Integrated Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Biopharma is operating at the current time. Most of Integrated Biopharma's value examination focuses on studying past and present price action to predict the probability of Integrated Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Biopharma's price. Additionally, you may evaluate how the addition of Integrated Biopharma to your portfolios can decrease your overall portfolio volatility.